Expert Advice 27 May 2020Why Listening to Patient Organizations is Key in Drug Development As the biotech industry flourishes and therapies become more targeted and personalized, the need for drug developers to interact with… May 27, 2020 - 11 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
More News! 11 Oct 2019RNA Therapy Improves Vision in Untreatable Genetic Blindness A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the… October 11, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 23 Oct 2018Bridging the Academia-Industry Divide: Lessons from a Serial Biotech Entrepreneur What does it take to be a successful biotech entrepreneur? I put this and other similar questions to Dinko Valerio,… October 23, 2018 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 5 Sep 2018RNA Therapy Improves Vision in Patients with Rare Genetic Blindness Dutch company ProQR has released data from a Phase I/II trial showing its RNA therapy can improve the vision of… September 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 12 Mar 2018A Dutch Company on the Quest Against Cystic Fibrosis ProQR is the result of a personal quest against cystic fibrosis started by its CEO, Daniel de Boer. Interested in… March 12, 2018 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2018ProQR Tackles Blindness Caused by a Rare Genetic Disease ProQR has received €6M from the American charity, Foundation Fighting Blindness, for the development of its treatment for Usher Syndrome -… February 13, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2018Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA Galapagos and ProQR will work together to target fibrosis using a technology to treat genetic diseases without permanent changes to… January 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2017RNA Therapy for Rare Skin Disease Gets Orphan Status The EMA has granted orphan drug designation to ProQR's QR-313, a possible first disease-modifying treatment for the rare disease dystrophic… November 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2017Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low ProQR is aiming to raise funds for clinical trials on the Nasdaq despite the fact that its stock has been… November 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 25 Oct 2017What Could RNA Therapies Do for the Treatment of CNS Disorders? Evelyn chatted with Thomas de Vlaam to find out what his company, Amylon, is working on and how it hopes… October 25, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 14 Sep 2017New Dutch Spin Out will Treat Stroke with RNA Therapy ProQR has spun out Amylon Therapeutics, a company that will treat central nervous system disorders with a lead candidate based… September 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Feb 2017Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden! Known for its charming canals and tulip fields, Leiden is a major tourist attraction in the Netherlands. It is also home… February 28, 2017 - 7 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 19 Aug 2014ProQR Therapeutics files for a $75m IPO to compete with Vertex Pharmaceuticals ProQR Therapeutics is a Netherlands-based biotech company focused on developments of drugs to treat genetic disorders. Daniel de Boer, Gerard Platenburg, Dinko… August 19, 2014 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email